Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Clinical trial NCT00130897 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00130897
- Sponsor
- Pfizer
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2005-07-01
- Primary completion
- 2011-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.